Navigation Links
InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance
Date:10/1/2009

With Zap-CHO, customers get the animal free benefit of hydrolysates, the performance of FBS and the consistency of a defined media.

Fort Collins, CO (PRWEB) October 4, 2009 -- InVitria has launched a new and robust cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO. Zap-CHO is designed to deliver superior growth, maximum antibody productivity and faster cell line development and seed train expansion.

"Zap-CHO is a significant breakthrough in mammalian cell culture systems," said Dr. Steve Pettit, InVitria's Director of Cell Culture Development. "With the development of Zap-CHO, InVitria has created a performance enhancing CHO media supplement that is the first animal free supplement capable of replacing fetal bovine serum (FBS) without sacrificing performance and maintaining a well defined media. Since Zap-CHO is a defined and animal component-free product, it is well suited for commercial, chemically-defined and serum- and animal-free cell culture media formulations," said Dr. Pettit.

Zap-CHO is a next generation media supplement that delivers consistent cell culture performance. Previously, only FBS could deliver equivalent performance, but safety concerns of a fetal bovine component in cell culture media forced many customers away from this component. In the last decade, customers have eliminated FBS in cell culture media only to lose cell culture performance. To regain the lost performance, many began adding hydrolysates to the media. However, hydrolysates introduced significant variability, leading to failed experiments and production failures. Zap-CHO addresses these concerns and provides significant benefits in CHO cell culture, including:

 
  • Faster cell line development and seed train expansion
  • Animal component-free
  • Consistency of a defined media component
  • Biomanufacturing optimization and improved production economics
  • Better and more predictable performance in cell culture research and development

"Our product development team created Zap-CHO to exceed the needs of our customers working in CHO cell culture," said Scott Deeter, InVitria's President and CEO. "Our customers have realized exceptional performance results using Zap-CHO. InVitria's products, like Zap-CHO, are creating a new era for the cell culture manufacturing industry."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's products or to order, please contact InVitria at info@invitria.com or call 1-800-916-8311. InVitria's products can also be purchased online Click Here.

###

Read the full story at http://www.prweb.com/releases/InVitria-ZapCHO/CHO-cell-culture-media/prweb2975014.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
2. InVitria Presents Zap-CHO Performance Results at PEACe Conference
3. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
4. InVitria Cell Culture Product Line to Headline PEACe
5. InVitria Sponsors ESACT 2009 in Dublin, Ireland
6. InVitria to Present at BIO 2009 International Convention in Atlanta
7. InVitria Reveals Technology to Optimize Hybridoma Production Performance
8. InVitria Headlines Sponsorship of WilBio's Waterside Conference
9. InVitria Announces Launch of Recombinant Albumin for Diagnostics
10. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
11. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... Hills of Pittsburgh now have easier access to the robotic-assisted total-hip and ... Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson Hospital recently ...
(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the ... American office location in Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd ... Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond Levar M. Stoney. ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... CARTERSVILLE, Georgia (PRWEB) , ... March 28, 2017 ... ... analyst to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, ... been a leader in the real estate valuation industry for more than 40 ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Varian Medical Systems (NYSE: VAR ... second quarter of fiscal year 2017 following the close of ... will be followed by a teleconference available to all interested ... link to the conference call webcast will be available on ... teleconference call and replay: ...
(Date:3/29/2017)... , March 29, 2017   Royal Philips ... in health technology, and PathAI, a company that ... with the aim to develop solutions that improve ... cancer and other diseases. The partnership aims to ... this form of artificial intelligence to be applied ...
(Date:3/29/2017)... , March 29, 2017 Neurim Pharmaceuticals ... Exeltis will obtain exclusive marketing rights for Neurim,s new Rx PedPRM ... ... targeted to treat sleep disorders in children with Autism Spectrum Disorders ... sleep medication approved for children. The collaboration with Exeltis ...
Breaking Medicine Technology: